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Abstract
Background Gastric banding (GB) is one of the most
popular bariatric procedures for morbid obesity. Apart from
causing weight loss by alimentary restriction, it can interfere
with functions of the esophagus and upper stomach. The aim
of this study was to evaluate if the results of extensive
preoperative upper GI testing were correlated with long-term
outcome and complications after GB.
Methods Using a prospectively maintained computerized
database including all the patients undergoing bariatric
operations in both our hospitals, we performed a retrospec-
tive analysis of the patients who underwent complete upper
gastrointestinal (GI) testing (endoscopy, pH monitoring,
and manomatry) before GB.
Results One hundred thirty-four patients underwent com-
plete testing before GB. Abnormal pH monitoring (in-
creased total reflux time, increased diurnal reflux time,
increased number of reflux episodes) predicted the devel-
opment of complications and especially pouch dilatation
and food intolerance. The mean De Meester score was
higher among patients who developed complications than
in the remaining ones (25.4 vs 17.7, P=0.03). High lower
esophageal sphincter pressure also predicted progressive
long-term food intolerance. Endoscopic findings were not
predictive of the long-term outcome.
Conclusions There is some association between the func-
tion of the upper digestive tract and long-term complica-
tions after gastric banding. Abnormal pH monitoring
predicts overall long-term complications, especially food
intolerance with or without reflux, and pouch dilatation,
and a high lower esophageal sphincter pressure predicts
long-term food intolerance. Extended upper gastrointestinal
testing with endoscopy, 24-h pH monitoring, and esopha-
geal manometry is probably worthwhile in selecting
patients for gastric banding.
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Introduction
The prevalence of overweight and obesity has increased
markedly in the western world during the past three
decades. Obesity significantly reduces quality of life, is
responsible for a large number of comorbid medical
conditions, and reduces life expectancy. Despite the refine-
ments of diet therapy and the recent development of new
drugs, bariatric surgery is still the only means to provide
patients with effective and durable weight loss. The
important weight reduction that follows bariatric procedures
has been shown to not only increase quality of life but also
to improve or reverse comorbidities and reduce obesity-
related mortality especially from cardiovascular disease and
cancer [1–5].
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Laparoscopic gastric banding, being the first minimally
invasive approach to morbid obesity, was soon adopted as a
very safe, simple, and reversible bariatric procedure by
many surgeons especially in Europe, Australia, and Latin
America, with early results in terms of weight loss
comparable to those of other restrictive operations. With
time, however, it became apparent that in the long term, a
significant number of patients do not achieve sufficient
weight loss or develop complications that jeopardize the
overall results of the procedure [6]. So far, very little is
known about the reasons why some patients develop
complications and others do not. Patient’s compliance,
and especially eating behavior, has been blamed among
others, and large hiatus hernias have traditionally been
considered as a contraindication for gastric banding (GB)
by most surgeons. Morbidly obese patients are known to
have a high prevalence of gastroesophageal reflux disease
(GERD) and esophageal motility disorders. In a cohort of
345 morbidly obese patients awaiting bariatric surgery, we
found a hiatus hernia in 52.6%, reflux esophagitis in 31.4%,
and an elevated De Meester score at 24-h pH monitoring in
51.7% of the patients. In the same group, manometry was
altered in 25.6% of the patients [7]. GB has been shown to
have various effects on reflux. It can act as an antireflux
procedure or it can enhance GERD [8–13]. GB also rapidly
alters esophageal motility, with a decrease in the amplitude
of contractions in the lower esophagus as soon as 9 months
after surgery [13]. Whether the preoperative functional
status of the esophagus and gastroesophageal junction plays
a role in the long-term results of gastric banding, and
especially in the development of complications, is largely
unknown. So far, a single study by Lew et al. [14] has
evaluated the relationship between preoperative manometry,
weight loss, vomiting, and the diameter of the esophagus
during the first two postoperative years. In a group of 77
patients, these authors found no correlation between
manometry and weight loss or the esophageal diameter,
but more severe vomiting in patients with an abnormal
manometry. The aim of the present study was to evaluate,
in a larger group of morbidly obese patients submitted to
gastric banding and followed up for a long period of time,
whether long-term outcome of gastric banding with respect
to weight loss or the development of long-term complica-
tions could be predicted by the results of extended upper
gastrointestinal testing with endoscopy, 24-h pH monitor-
ing, and manometry.
Patients and Methods
In our two institutions, a multidisciplinary team evaluated
all morbidly obese patients presenting for bariatric surgery.
Between January 1999 and April 2003, once indication for
surgery was confirmed according to the consensus devel-
opment conference panel of the National Institute of Health
and to the consensus on obesity treatment in Switzerland
[15, 16] and contraindications were excluded, patients were
evaluated for digestive symptoms and underwent complete
upper gastrointestinal objective testing with endoscopy,
24-h pH monitoring, and stationary esophageal manometry.
Esophagogastroduodenoscopy was performed using a stan-
dard gastrofibroscope. A hiatus hernia was diagnosed if the
distance between the Z-line and the hiatus opening was more
than 1 cm. Esophagitis was graded according to the modified
Savary–Miller classification [17]. Esophageal manometry
testing was performed using perfused eight-lumen catheters
SE-25381_4+4 (Sedia, Givisiez, Switzerland). Esophageal
body function was assessed with the four proximal pressure
transducers. The distance between the transducers was 5 cm.
The function of the lower esophageal sphincter (LES) was
assessed by four pressure transducers placed at the same
level, one in each quadrant. During the procedure, the
patients performed ten wet and ten dry swallows. Manom-
etry data were analyzed with the Sedia NT Oes software
(Sedia). Twenty-four hours pH monitoring was performed
with the glass electrodes F8-IR (Simtec, Basel, Switzerland).
The distal tip of the probe was placed 5 cm above the
gastroesophageal junction. The patient was monitored for
24 h, and pH data were recorded on a data logger Gastro-
graph (new name pH-graph, Simtec) downloaded onto a PC
and analyzed with the MIC Gastro V1.7 software (MIC,
Solothurn, Switzerland).
The LES pressure was considered normal between 10
and 45 mmHg. Incomplete relaxation of the LES was
defined as a less than 70% relaxation only. Nutcracker
esophagus was diagnosed if the mean contraction amplitude
was above 180 mmHg in the lower esophagus. Non-
specific motility disorders were defined as either amplitude
of the contraction wave below 30 mmHg in the lower
esophagus and/or as the existence of more than 30% non-
peristaltic contractions. The results of pH monitoring were
considered abnormal with a De Meester score >14.7. In our
laboratory, the cutoff values for the results of pH-metry
were as follows: 4.7% for the total reflux time, 8.3% for
daily reflux, 3.3% for nocturnal reflux, 50 for the total
number of reflux episodes, 4 for the number of prolonged
reflux episodes, and 20 min for the longest reflux duration.
Gastric banding was the only bariatric procedure offered
at the beginning of this study. Roux-en-Y gastric bypass was
slowly introduced since June 1999 and first offered mostly
to superobese patients before being proposed to all patients.
The choice of procedure was then made together with the
patient after complete information and a long discussion
regarding pros and cons. All the operations were performed
laparoscopically under general anesthesia. The operative
technique used for GB has been described elsewhere [18].
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Briefly, the Lapband® (Bioenterics, Carpinteria, CA, USA)
was placed using the perigastric technique, and the SAGB®
(Obtech medical for Ethicon Endosurgery, 6310 Zug,
Switzerland) was placed according to the pars flaccida
technique. All the patients included in this series were part
of a randomized prospective trial, which intended to
compare the results between these two bands [19]. A large
hiatus hernia (>2 cm) was considered as a contraindication
to GB.
Both the surgical and medical team followed patients. All
patients’ data were entered prospectively in a computerized
database. In a retrospective analysis, weight loss and
complications in patients who underwent gastric banding
were evaluated according to the results of preoperative upper
gastrointestinal tests.
Major long-term complications were defined as pouch
dilatation with or without band slippage, severe food
intolerance ± symptomatic reflux, esophageal dilatation, band
erosion, and any other complication leading to band removal
such as band leak. Failure was considered in patients inwhom
thebandhad tobe removedor in thosewho failed to achieve an
excess weight loss of at least 25%.
Statistical analysis was performed using the Student’s t
test for numerical variables and with the chi-square or exact
Fisher’s test for categorical variables as appropriate.
Statistical significance was accepted at a p level <0.05.
Results
Complete datasets were available for a total of 134 patients,
113 women and 21 men, with a mean age of 38 years
(21–64). The mean preoperative body mass index (BMI)
was 42.7 kg/m2 (34.3–53.2). Sixty-six patients had a small
(<2 cm) hiatus hernia, and 71 (53.8%) had GERD as
proven by the presence of esophagitis at preoperative
endoscopy and/or a pathologic preoperative De Meester
score at 24-h pH-metry. Twenty-five (18.9%) patients had a
pathologic esophageal manometry, the most common
finding being a low LES pressure. These figures correspond
roughly to what we found in a large group of morbidly
obese patients scheduled for bariatric surgery [12]. Gastric
banding was done with a Lapband® in 64, and a SAGB® in
70 patients. Duration of follow-up was between 51 and
106 months (mean 85). The mean% of excess BMI loss for
patients who retained the band was 65.2, 64.3, and 64.1
after 3, 5, and 7 years, respectively. A total of 44 patients
(32.8%) developed at least one major long-term complica-
tion (Table 1), of which 38 (28.3%) so far required band
removal with or without conversion to another bariatric
procedure. Because of insufficient weight loss or band
removal, 54 patients (40.3%) were considered as failures.
We could not find any relationship between the results of
any preoperative digestive tests and weight loss or the
overall failure rate. Contrary to what we expected, the
results of endoscopy, and especially the presence of a hiatus
hernia or esophagitis, were not predictive of any type of
complication. There was, however, a relationship between
the results of 24-h pH monitoring and the overall
complication rate. The mean De Meester score was higher
(25.4 vs 17.7, p=0.03) in patients who developed compli-
cations. More specifically, complications were more com-
mon in patients with an elevated daily reflux time (47.2 vs
24.4%, p=0.02), and there was a trend for more complica-
tions in patients with an increased total reflux time (41.7 vs
26%, p=0.07).
Considering specific complications, the mean preopera-
tive LES pressure was higher (24 vs 17.3 cm H2O, p=0.05)
in patients who developed severe late food intolerance and/
or reflux. The latter were also more common in patients
with long reflux episodes (3 vs 14.3%, p=0.05) than in
those without this finding at 24-h pH monitoring. Pouch
dilatation with or without slippage was more common in
patients who received a Lapband® than in those with a
SAGB®. This complication was clearly related to findings
Table 1 Long-term complications
Type of complication Number Percentage
Pouch dilatation with or without slippage 9 6.7
Esophageal dilatation 12 8.9
Severe food intolerance with or without
reflux
8 5.9
Band erosion 16 11.9
Others 3 2.2
Total patients with major complications 44 32.8
Table 2 Relationship between
findings of 24-h pH monitoring
and the occurrence of late
pouch dilatation with or with-
out slippage
% Patients with pouch dilatation with or without slippage p value
Normal Elevated
De Meester score 1.7 13.4 0.03
% Total reflux time 1,3 17.1 0.005
% Daily reflux time 1.2 24.1 <0.001
Number of long reflux episodes 3.2 20.8 0.01
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at pH monitoring (Table 2) and was more frequent in
patients with abnormal findings. We could not demonstrate
any correlation between preoperative tests and late esoph-
ageal dilatation, especially regarding results of preoperative
manometry, nor did we find any relationship between late
band erosion/migration and preoperative tests.
Discussion
Laparoscopic gastric banding is considered the safest
bariatric procedure, with a low operative morbidity, and
mortality usually below 0.1%. In the majority of operated
patients, GB produces effective weight loss because of food
restriction, with variable degrees of food intolerance and
vomiting. Satisfactory weight loss, in the early postopera-
tive years, is obtained in approximately two thirds of
patients [20]. With increasing length of follow-up, however,
a growing number of long-term complications arise, such as
pouch dilatation with or without slippage, band erosion,
progressive esophageal dilatation with pseudoachalasia,
food intolerance with gastroesophageal reflux, band leaks.
These complications are sometimes difficult to manage and
often lead to progressive weight regain. Reasons why some
patients tolerate the band very well and others develop
complications are essentially unknown, although eating
behavior, which shows abnormal patterns in the majority of
morbidly obese patients, and preexisting conditions of the
upper gastrointestinal tract like hiatus hernia, GERD, and
esophageal motility disorders have been incriminated. It
would be of interest to be able to better select morbidly
obese patients for gastric banding and exclude from this
procedure those in whom long-term complications can be
anticipated on the basis of preoperative factors.
In the present study, the first of this type to the best of
our knowledge, we confronted the results of extended upper
gastroesophageal testing with long-term results of gastric
banding in 134 fully investigated patients. The results of
preoperative endoscopy did not correlate with long-term
morbidity, but some correlations were found between the
results of 24-h pH monitoring or esophageal manometry
and complications. Patients who developed any type of
long-term complications tended to have a higher De
Meester, although the mean score in both groups were
abnormally elevated. More reflux was especially associated
with late pouch dilatation with or without band slippage.
The latter complication was also more common in patients
operated with a Lapband® than in those with a SAGB®.
This is most probably related to the operative technique.
The Lapband® were placed using the perigastric technique
and the SAGB® using the pars flaccida technique, and it
has been shown that the latter reduces the frequency of
pouch dilatation [21]. Long reflux episodes were associated
with poor late food tolerance, and patients who developed
this complication also had a higher preoperative LES
pressure than those who did not. As has been recognized,
reflux in morbidly obese patients is mostly caused by
transient LES relaxation [22]. It may be that in these
patients, a high resting LES disturbs esophageal clearance
between reflux episodes, thereby increasing esophageal
exposure to acid and residual food.
Others have studied the relationship between preoperative
esophageal manometry and outcome after laparoscopic
gastric banding [19]. Like us, they found no correlation
between the results of this test and early weight loss, but they
noticed more severe vomiting in patients with abnormal
manometry. This is partly in accordance with our results.
Duration of follow-up, however, was limited in the latter
study, so that late effects of preoperative manometry results
could not be assessed. We are not aware of any published
study inwhich the results of preoperative 24-h pHmonitoring
were confronted with long term outcome of gastric banding.
Conclusions
On the basis of our results, we believe that there is some
association between the function of the upper digestive tract
and long-term complications after gastric banding. Abnor-
mal pH monitoring predicts overall long-term complica-
tions, especially food intolerance with or without reflux and
pouch dilatation, and a high LES pressure predicts long-
term food intolerance. Extended upper gastrointestinal
testing with endoscopy, 24-h pH monitoring, and esopha-
geal manometry is probably worthwhile in selecting
patients for gastric banding. Confronting complete preop-
erative evaluation with long-term outcome in a much larger
group of patients would probably help to better understand
the precise relationship that may exist and the mechanisms
by which complications develop.
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